Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001213900-26-081135
Filing Date
2026-07-24
Accepted
2026-07-24 09:00:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea0299103-424b5_chinasxt.htm 424B5 321877
  Complete submission text file 0001213900-26-081135.txt   322939
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU China
Business Address 178 TAIDONG ROAD NORTH TAIZHOU China 8652386298290
China SXT Pharmaceuticals, Inc. (Filer) CIK: 0001723980 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: 424B5 | Act: 33 | File No.: 333-291428 | Film No.: 261198637
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)